Success Metrics

Clinical Success Rate
50.0%

Based on 1 completed trials

Completion Rate
50%(1/2)
Active Trials
0(0%)
Results Posted
200%(2 trials)
Terminated
1(33%)

Phase Distribution

Ph phase_4
1
33%
Ph not_applicable
2
67%

Phase Distribution

0

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution3 total trials
Phase 4Post-market surveillance
1(33.3%)
N/ANon-phased studies
2(66.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

33.3%

1 of 3 finished

Non-Completion Rate

66.7%

2 ended early

Currently Active

0

trials recruiting

Total Trials

3

all time

Status Distribution
Completed(1)
Terminated(2)

Detailed Status

Withdrawn1
Terminated1
Completed1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
0
Success Rate
50.0%
Most Advanced
Phase 4

Trials by Phase

Phase 41 (33.3%)
N/A2 (66.7%)

Trials by Status

withdrawn133%
terminated133%
completed133%

Recent Activity

0 active trials
Showing 3 of 3
completednot_applicable

Comparing Synthetic Hybrid-Scale Fiber Matrix With Standard of Care in Treating Diabetic Foot Ulcers

NCT04918784
withdrawnphase_4

RCT to Compare Restrata and NPWT to Heal Complex DFUs

NCT04405050
terminatednot_applicable

Utility of Restrata With Split Thickness Skin Graft to Reconstruct the Forearm Donor Site

NCT04829331

Clinical Trials (3)

Showing 3 of 3 trials
NCT04918784Not Applicable

Comparing Synthetic Hybrid-Scale Fiber Matrix With Standard of Care in Treating Diabetic Foot Ulcers

Completed
NCT04405050Phase 4

RCT to Compare Restrata and NPWT to Heal Complex DFUs

Withdrawn
NCT04829331Not Applicable

Utility of Restrata With Split Thickness Skin Graft to Reconstruct the Forearm Donor Site

Terminated

All 3 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
3